The Minnesota bill for infertility treatments mandates comprehensive insurance coverage for diagnosis, IVF, and fertility preservation across public and private health plans. Set for implementation in 2027, the legislation expands access, modernises infertility definitions, and ensures cost-sharing protections to make reproductive healthcare more equitable.


The landscape of reproductive healthcare in the Midwest is poised for a significant transformation following the advancement of SF 1961. This Minnesota bill for infertility treatments seeks to eliminate the financial and diagnostic barriers that have historically hindered family-building for thousands of residents. By mandating that any health plan offering maternity benefits must also cover infertility care, the state is moving toward a model where reproductive medicine is treated as a fundamental component of healthcare.
A primary pillar of the legislation is its commitment to healthcare equity. Under the new requirements, the state’s public health programs Medical Assistance and MinnesotaCare, will be required to cover infertility diagnosis, treatment, and preservation services. This move is designed to ensure that a resident's socioeconomic status does not dictate their ability to access advanced medical interventions like IVF or egg freezing.
The Minnesota bill for infertility treatments also addresses the needs of patients facing "iatrogenic" infertility, requiring coverage for preservation services when a medical treatment, such as chemotherapy, poses a risk to future fertility.
The bill’s inclusive definition of infertility marks a departure from restrictive older statutes. It recognises infertility based on a patient’s medical and reproductive history or their inability to reproduce as a single individual or with a partner, effectively broadening access for the LGBTQ+ community and single parents by choice. Clinically, the mandate requires that treatments align with the professional standards set by the American Society for Reproductive Medicine. While the bill allows insurance providers to cap completed oocyte retrievals at four, it mandates unlimited embryo transfers, prioritising the most effective path to a live birth.
To protect patients from predatory plan designs, the legislation includes strict cost-sharing protections. Health plans are forbidden from applying waiting periods, referral requirements, or benefit maximums to infertility care that do not also apply to standard maternity coverage. This ensures that the Minnesota bill for infertility treatments provides meaningful financial relief rather than just theoretical access.
The implementation of these changes is scheduled for January 1, 2027, for all plans issued or renewed on or after that date. To assist with the transition, the state has established a reimbursement framework where the commissioner of commerce will use general fund appropriations to defray the additional costs incurred by health plan companies. This legislative framework represents a systemic effort to integrate fertility care into the standard continuum of medical services in Minnesota
